Previous study showed, in metastatic colorectal cancer patients treated with EGFR inhibitor, patients harboring at least one minor allele of rs2227983 G > A were more likely to show a higher tumor response as compared to those with homozygous wild-type allele43. Here, EGFR is linked to neoplasm.